Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 8
31 juil. 2014 16h00 HE
|
Progenics Pharmaceuticals Inc.
TARRYTOWN, N.Y., July 31, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer,...